HK1216843A1 - Methods and compositions for administration of oxybutynin - Google Patents

Methods and compositions for administration of oxybutynin

Info

Publication number: HK1216843A1
Authority: HK; Hong Kong
Prior art keywords: oxybutynin; administration; compositions; methods
Prior art date: 2012-12-27

Application number

HK16104715.8A

Other languages

Chinese (zh)

Inventor

Cook Robert

a byron David

Fleming Scott

Original Assignee

Microdose Therapeutx Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-12-27

Filing date

2016-04-25

Publication date

2016-12-09

2012-12-27 Priority claimed from US13/728,706 external-priority patent/US9119777B2/en

2016-04-25 Application filed by Microdose Therapeutx Inc filed Critical Microdose Therapeutx Inc

2016-12-09 Publication of HK1216843A1 publication Critical patent/HK1216843A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Otolaryngology (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

HK16104715.8A 2012-12-27 2016-04-25 Methods and compositions for administration of oxybutynin HK1216843A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US13/728,706 US9119777B2 (en)	2008-05-30	2012-12-27	Methods and compositions for administration of oxybutynin
PCT/US2013/074759 WO2014105446A1 (en)	2012-12-27	2013-12-12	Methods and compositions for administration of oxybutynin

Publications (1)

Publication Number	Publication Date
HK1216843A1 true HK1216843A1 (en)	2016-12-09

Family

ID=51021931

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
HK16103431.3A HK1215396A1 (en)	2012-12-27	2016-03-23	Methods and compositions for administration of oxybutynin
HK16104715.8A HK1216843A1 (en)	2012-12-27	2016-04-25	Methods and compositions for administration of oxybutynin

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
HK16103431.3A HK1215396A1 (en)	2012-12-27	2016-03-23	Methods and compositions for administration of oxybutynin

Country Status (15)

Country	Link
EP (1)	EP2938329A4 (en)
JP (1)	JP2016504358A (en)
KR (1)	KR20150100902A (en)
CN (1)	CN104955444A (en)
AR (1)	AR094287A1 (en)
AU (1)	AU2013368298B2 (en)
BR (1)	BR112015015421A2 (en)
CA (1)	CA2895955A1 (en)
EA (1)	EA201591218A1 (en)
HK (2)	HK1215396A1 (en)
IL (1)	IL239623A0 (en)
MX (1)	MX2015008333A (en)
NZ (1)	NZ628479A (en)
UY (1)	UY35230A (en)
WO (1)	WO2014105446A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3421049B1 (en) *	2016-02-25	2020-07-29	Hisamitsu Pharmaceutical Co., Inc.	Liquid external preparation
US20230286900A1 (en) *	2020-05-05	2023-09-14	Apnimed, Inc. (Delaware)	Polymorphic forms of (r)-oxybutynin hydrochloride

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1191930A2 (en) *	1999-05-20	2002-04-03	Sepracor Inc.	Methods for treatment of asthma using s-oxybutynin
US6339107B1 (en) *	2000-08-02	2002-01-15	Syntex (U.S.A.) Llc	Methods for treatment of Emphysema using 13-cis retinoic acid
EP1558563A1 (en) *	2002-10-29	2005-08-03	Pharmacia & Upjohn Company LLC	Quaternary ammonium compounds
GB0410398D0 (en) *	2004-05-10	2004-06-16	Arakis Ltd	The treatment of respiratory disease
CA2585122A1 (en) *	2004-10-25	2006-05-04	Schering Corporation	M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders
US8415390B2 (en) *	2008-05-30	2013-04-09	Microdose Therapeutx, Inc.	Methods and compositions for administration of oxybutynin
EP3311820A1 (en) *	2008-02-26	2018-04-25	Sunovion Respiratory Development Inc.	Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
WO2010147631A1 (en) *	2009-06-16	2010-12-23	Wen Tan	Use of r-bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders
GB0918450D0 (en) *	2009-10-21	2009-12-09	Innovata Ltd	Composition
WO2011120779A1 (en) *	2010-04-01	2011-10-06	Chiesi Farmaceutici S.P.A.	Process for preparing carrier particles for dry powders for inhalation
EP2621588A4 (en) *	2010-09-27	2014-09-03	Microdose Therapeutx Inc	Methods and compositions for disease treatment using inhalation

2013
- 2013-12-12 WO PCT/US2013/074759 patent/WO2014105446A1/en active Application Filing
- 2013-12-12 NZ NZ628479A patent/NZ628479A/en not_active IP Right Cessation
- 2013-12-12 JP JP2015550444A patent/JP2016504358A/en active Pending
- 2013-12-12 EP EP13867956.8A patent/EP2938329A4/en not_active Withdrawn
- 2013-12-12 AU AU2013368298A patent/AU2013368298B2/en not_active Ceased
- 2013-12-12 BR BR112015015421A patent/BR112015015421A2/en not_active IP Right Cessation
- 2013-12-12 EA EA201591218A patent/EA201591218A1/en unknown
- 2013-12-12 MX MX2015008333A patent/MX2015008333A/en unknown
- 2013-12-12 CN CN201380068230.5A patent/CN104955444A/en active Pending
- 2013-12-12 KR KR1020157020335A patent/KR20150100902A/en not_active Ceased
- 2013-12-12 CA CA2895955A patent/CA2895955A1/en not_active Abandoned
- 2013-12-20 UY UY0001035230A patent/UY35230A/en not_active Application Discontinuation
- 2013-12-27 AR ARP130105037A patent/AR094287A1/en unknown
2015
- 2015-06-24 IL IL239623A patent/IL239623A0/en unknown
2016
- 2016-03-23 HK HK16103431.3A patent/HK1215396A1/en unknown
- 2016-04-25 HK HK16104715.8A patent/HK1216843A1/en unknown

Also Published As

Publication number	Publication date
AU2013368298B2 (en)	2016-08-11
UY35230A (en)	2015-01-30
BR112015015421A2 (en)	2017-07-11
EA201591218A1 (en)	2015-11-30
JP2016504358A (en)	2016-02-12
CA2895955A1 (en)	2014-07-03
NZ628479A (en)	2016-06-24
AU2013368298A1 (en)	2015-07-02
IL239623A0 (en)	2015-08-31
HK1215396A1 (en)	2016-08-26
EP2938329A4 (en)	2016-08-10
AR094287A1 (en)	2015-07-22
KR20150100902A (en)	2015-09-02
MX2015008333A (en)	2015-11-09
WO2014105446A1 (en)	2014-07-03
CN104955444A (en)	2015-09-30
EP2938329A1 (en)	2015-11-04

Publication	Publication Date	Title
HK1251246A1 (en)	2019-01-25	Methods and compositions for desulfurization of compositions
ZA201508059B (en)	2016-12-21	Compositions and methods of use of phorbol esters
AP3965A (en)	2016-12-24	Anthelminitic compounds and compositions and method of using thereof
EP2675471A4 (en)	2015-01-28	Hsa-related compositions and methods of use
HRP20180633T1 (en)	2018-06-01	Methods for the preparation and delivery of fuel compositions
HK1216503A1 (en)	2016-11-18	Compositions and methods for transdermal delivery of amphetamine
EP2897639A4 (en)	2016-05-04	Improved vaccine compositions and methods of use
HK1203815A1 (en)	2015-11-06	Pharmaceutical compositions and methods for their preparation
HK1203149A1 (en)	2015-10-23	Novel dosage form and formulation of abediterol
EP2906041A4 (en)	2016-10-26	Compositions and methods of use of an inappetance-controlling compound
EP2867199A4 (en)	2015-12-02	Stable compositions of fesoterodine
HK1216843A1 (en)	2016-12-09	Methods and compositions for administration of oxybutynin
EP2814907A4 (en)	2015-11-04	Boron-loaded liquid scintillator compositions and methods of preparation thereof
HK1212998A1 (en)	2016-06-24	Ron compositions and methods of use thereof ron
AU2012905317A0 (en)	2012-12-20	Methods and Preparation and Use of Xanthorrhoeaceae Compositions
AU2012901658A0 (en)	2012-05-10	Compositions and methods of use
GB201207064D0 (en)	2012-06-06	Pharmaceutical compositions comprising 15-hetre and methods of using the same